Workflow
KINGLAND TECHNOLOGY(000711)
icon
Search documents
18天15板!ST京蓝2月27日起停牌核查
Bei Jing Shang Bao· 2026-02-26 13:12
ST京蓝表示,经公司自查并向控股股东、实际控制人核实,截至公告披露日,公司不存在应披露而未 披露的重大事项。 北京商报讯(记者 王蔓蕾)2月26日晚间,ST京蓝(000711)披露公告称,公司将就股票交易波动情况 进行核查。公司股票自2月27日起停牌,待核查结束并披露相关公告后复牌,预计停牌时间不超过3个交 易日。 交易行情显示,2月26日,ST京蓝涨停收盘,收于涨停价3.64元/股,总市值104亿元。拉长时间来看,1 月26日—2月26日这18个交易日内,公司累计斩获15个涨停板。 ...
ST京蓝(000711.SZ):股票短期内价格涨幅较大 停牌核查
Ge Long Hui A P P· 2026-02-26 13:03
Core Viewpoint - ST Jinglan (000711.SZ) has experienced a significant stock price increase of 116.67% from January 23, 2026, to February 26, 2026, which has raised concerns about the disconnection between stock performance and company fundamentals [1] Stock Performance - The stock price of ST Jinglan has shown abnormal fluctuations multiple times during the specified period, including one instance of severe abnormal volatility [1] - The company acknowledges that the short-term price increase is significantly detached from its performance metrics [1] Company Actions - To protect investor interests, the company will conduct an investigation into the stock trading fluctuations [1] - Following the company's application, trading of ST Jinglan's stock will be suspended starting February 27, 2026, until the investigation is completed and relevant announcements are made, with an expected suspension period not exceeding three trading days [1]
ST京蓝(000711) - 关于公司股票交易异常波动情况暨停牌核查的公告
2026-02-26 12:45
京蓝科技股份有限公司 关于公司股票交易异常波动情况暨停牌核查的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 特别提示: 证券代码:000711 证券简称:ST 京蓝 公告编号:2026-020 1、京蓝科技股份有限公司(以下简称"公司"、"上市公司")的股票(证 券简称:ST 京蓝,证券代码:000711)于 2026 年 2 月 24 日、2026 年 2 月 25 日、2026 年 2 月 26 日连续 3 个交易日收盘价格涨幅偏离值累计超过 13.13%,根 据深圳证券交易所的有关规定,属于股票交易异常波动情形。 公司股票自 2026 年 1 月 23 日至 2026 年 2 月 26 日期间价格涨幅为 116.67%, 期间多次触及股票交易异常波动情形、1 次触及严重异常波动情形,公司股票短 期内价格涨幅较大,严重脱离公司业绩情况。为维护投资者利益,公司将就股票 交易波动情况进行核查。经公司申请,公司股票(证券简称:ST 京蓝,证券代 码:000711)自 2026 年 2 月 27 日开市起停牌,待核查结束并披露相关公告后复 牌,预计停牌时间 ...
昨日连板板块强势 汉缆股份涨停
Xin Lang Cai Jing· 2026-02-25 02:53
Group 1 - The article highlights a strong performance in the stock market, particularly in the "continuous limit-up" sector, with several companies experiencing significant gains [1] - Notable stocks that reached their daily limit include Hanlan Co., Roman Co., Farsen, ST Wanfang (rights protection), ST Jinglan (rights protection), ST Jinhong, and ST Rendo [1] - YN Energy Holdings also showed a notable increase in stock price, contributing to the overall positive market sentiment [1]
ST京蓝涨停走出4连板
Mei Ri Jing Ji Xin Wen· 2026-02-24 11:18
Group 1 - ST Jinglan has experienced a significant stock performance, achieving a limit-up and marking its fourth consecutive trading day of gains [1] - Over the past four days, the cumulative increase in ST Jinglan's stock price has reached 21.77% [1]
未知机构:ZY电新ST京蓝拟更名铟靶新材AI上游铟材料龙头市值严重低估02-20260224
未知机构· 2026-02-24 03:45
Summary of Conference Call Notes Company Overview - **Company**: ST Jinglan (to be renamed as Indium Target New Materials) - **Industry**: Indium materials for AI and semiconductor applications Key Points and Arguments Market Valuation - The company's full indium supply chain and AI computing materials suggest a future market value of approximately 40 billion, while the current market capitalization is only about 9 billion, indicating a significant undervaluation of AI upstream and target material production value [1][2] Supply Side Dynamics - China monopolizes global indium supply, with the company being a leading player in recycled indium. By 2025, refined indium production is expected to exceed 200 tons, capturing approximately 13.5% of the global market share. Following the injection of Xinlian Environmental Protection, total production capacity is anticipated to reach 700 tons, which is over five times that of Xiyie Co. [1] Demand Side Drivers - The demand for high-purity indium and ITO target materials is expected to surge due to applications in AI 800G/1.6T optical modules, CPO, and InP laser chips, confirming an upward price cycle for indium [1] Valuation Metrics - Following the removal of ST status and the name change, the company is transitioning from an environmentally challenged stock to a growth stock in AI upstream new materials. The price-to-earnings (PE) ratio is projected to shift from negative to positive, with a target PE range of 40-50X based on peer comparisons [2] Core Developments and Pricing - By 2026, the company plans to achieve mass production of 500 tons of ITO target materials, entering the optical module and photovoltaic supply chain, with a gross margin of over 30%, contributing to performance elasticity [3] - The completion of Xinlian Environmental Protection's injection in Q3 2026 is expected to double indium production capacity, solidifying the company's position as a global leader in recycled indium [3] - The anticipated name change and removal of ST status in August-September 2026 will enhance liquidity and attract institutional investment, leading to valuation recovery [3] - By 2027, high-purity indium and InP materials are expected to gradually materialize, opening long-term opportunities in AI chips, optical modules, and thermal management [3] Investment Thesis - The combination of the name change, indium price cycle, ITO target materials, AI computing materials, and asset injection presents multiple catalysts for the company, positioning it as a significantly undervalued asset in the AI upstream sector [3]
午间涨跌停股分析:87只涨停股、13只跌停股,贵金属板块活跃,白银有色、湖南白银涨停
Xin Lang Cai Jing· 2026-02-24 03:44
Market Overview - A total of 87 stocks reached the daily limit up, while 13 stocks hit the daily limit down in the A-share market on February 24 [1] - The precious metals sector was active, with silver-related stocks such as Hunan Silver hitting the limit up [1] Sector Performance - The MLCC (Multi-Layer Ceramic Capacitor) concept stocks strengthened, with Fenghua Hi-Tech and Yunzhu Technology reaching the limit up [1] - The fiberglass sector saw gains, with Honghe Technology and Shandong Fiberglass achieving limit up for three out of four days [1] Continuous Limit Up Stocks - ST Jinglan achieved 12 limit ups in 16 days, while ST Jinhong and *ST Wanfang recorded five consecutive limit ups [1] - Jin Niu Chemical had four limit ups in seven days, and other stocks like YN Energy and Meibang Shares had four consecutive limit ups [1] - Jiangxi Tungsten Equipment and Hanlan Shares recorded three consecutive limit ups, while Jin Zhengda had two limit ups in three days [1] Continuous Limit Down Stocks - *ST Jinglun and *ST Xiongmao faced three consecutive limit downs, while Decai Shares had two consecutive limit downs [1] - Other stocks such as *ST Guohua, Bona Film, and *ST Yuanshang also hit the limit down [1]
ST京蓝:如股价进一步异常上涨,可能申请停牌核查
Bei Ke Cai Jing· 2026-02-24 02:49
新京报贝壳财经讯 2月23日,ST京蓝发布公告称,公司股票于2026年2月11日、2月12日、2月13日连续3 个交易日收盘价格涨幅偏离值累计超过16.66%,属于股票交易异常波动情形。1月23日至2月13日期 间,公司股票价格涨幅为86.90%,短期内价格涨幅较大,公司业绩未发生重大变化,但近期公司股票 价格严重脱离公司业绩情况,投资者参与交易可能面临较大风险,如未来公司股票价格进一步异常上 涨,公司可能申请停牌核查。 ...
2月24日重要公告一览
Xi Niu Cai Jing· 2026-02-24 02:33
Group 1 - Tongce Medical's chairman and executives plan to increase their shareholding by 6 to 12 million yuan within six months, following recent purchases totaling approximately 1.34 million yuan [1] - Luxshare Precision has repurchased 9.9006 million shares for nearly 500 million yuan, representing 0.14% of its total share capital [2] - Jintai Construction's subsidiary won a project in Malaysia worth approximately 281 million yuan, accounting for 1.53% of the company's audited revenue for 2024 [3] Group 2 - Kela Co. announced the removal of independent director Jing Naiquan due to loss of independence and failure to fulfill duties [4] - Mingyang Smart Energy is planning to acquire 100% of Zhongshan Dehua Chip Technology Co., with ongoing audits and evaluations [5] - BGI Genomics intends to sell a subsidiary's equity for approximately 50 million USD and adjust licensing agreements [6] Group 3 - Guotou Capital reported that valuation adjustments at Guotou Ruijin Fund are expected to impact 2026 net profit by less than 5% [7] - Donghong Co. won a bid for a pressure steel pipe project worth 353 million yuan [9] - Yashi Chuangneng's major shareholder's shares, amounting to 2.9165% of total shares, will be auctioned, but it will not affect the company's operations [10] Group 4 - Frontier Biotech signed an exclusive licensing agreement with GlaxoSmithKline, receiving an upfront payment of 40 million USD and potential milestone payments totaling up to 950 million USD [11] - Kede CNC's major shareholders committed not to reduce their holdings for the next six months [12] - Richen Co. reported a 31.87% increase in net profit for 2025, driven by market expansion and operational efficiency [13] Group 5 - Jiayou International's PPP project in Zambia has officially commenced commercial operations and charging [14] - Junxin Co. updated its H-share listing application, pending approvals from regulatory bodies [15] - Shuangliang Energy's subsidiary won a bid for a 100 million yuan project in the Middle East [16][17] Group 6 - Baili Tianheng's drug candidate achieved primary endpoints in a Phase III clinical trial for triple-negative breast cancer [18] - ST Jinglan announced a significant stock price increase of 86.90% without major changes in performance, warning of potential stock suspension if prices continue to rise [19] - *ST Huiteng projected a revenue of 330 to 400 million yuan for 2025, with negative net profit expected [20]
15天12板!000711,或申请停牌核查
Group 1: Company Performance - Dayun Co., Ltd. reported a net profit of 84.21 million yuan for the year 2025, representing a year-on-year increase of 31.87% [8] - The total operating revenue for Dayun Co., Ltd. in 2025 was 468 million yuan, reflecting a growth of 15.7% compared to the previous year [8] Group 2: Major Events - Lixun Precision announced its first share buyback of 9.9006 million shares, costing nearly 500 million yuan [14] - ST Jinglan indicated that it may apply for a trading suspension if its stock price continues to rise abnormally, having increased by 86.90% from January 23 to February 13, 2026 [3][4] - Guotou Capital expects a negative impact on its 2026 net profit due to valuation adjustments of its silver futures investment fund, estimated to be less than 5% of its audited net profit for 2024 [5] Group 3: Corporate Actions - New Qianglian and Tongfu Microelectronics have had their applications for issuing shares to specific investors accepted by the Shenzhen Stock Exchange [10] - Reliable Co., Ltd. announced the removal of its independent director, Jing Naiquan, due to loss of independence and failure to fulfill duties [6] - Frontline Bio signed an exclusive licensing agreement with GlaxoSmithKline for two small RNA products, receiving an upfront payment of 40 million USD [12] Group 4: Project Wins - The company Jiayou International has officially commenced commercial operations on the Zambia Ndola to Sakanya highway, marking a significant milestone in its PPP project [15] - Donghong Co., Ltd. won a procurement project for pressure steel pipes and accessories worth 353 million yuan [14] - Shuangliang Energy's subsidiary won a project in the Middle East with an estimated value of 100.26 million yuan [16]